 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
MRC Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003
|
|
|
|
Phase IV
|
|
|
|
UKALL2003
NCT00222612
|
|
| |
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
|
|
|
|
Phase IV
|
|
|
|
2005-000658-56
20040177, 2004-41-4276, NCT00192673
|
|
| |
Study Treatment to Low Risk ALL
|
|
|
|
Phase IV
|
|
|
|
LAL-BR/2001
NCT00526175
|
|
| |
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
|
|
|
|
Phase IV
|
|
|
|
LAL-Ph-2000
NCT00526305
|
|
| |
Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
|
|
|
|
Phase IV
|
|
|
|
LAL-AR-N-2005
NCT00526409
|
|
| |
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
|
|
|
|
Phase IV
|
|
|
|
2006-00055-18
NCT00415103
|
|
| |
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
|
|
| |
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
|
|
|
|
Phase III, Phase II
|
|
|
|
Levosta-CBF-02/04
NCT00215007
|
|
| |
Stem Cell Transplantation for Hematological Malignancies
|
|
|
|
Phase III, Phase II
|
|
|
|
0005M52481
MT2000-12, NCT00176839
|
|
| |
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children (ESPHALL)
|
|
|
|
Phase III, Phase II
|
|
|
|
EUDRACT 2004-001647-30
PHRC/04-04, CIC0203/043, NCT00287105
|
|
